Salta al contenuto principale

Paolo E. Porporato

  • 2020-to date Associate Professor in Experimental Biology at the University of Turin, Torino, Italy 

  • 2016-2019 Assistant Professor in Experimental Biology at the University of Turin, Torino, Italy. 

  • 2015 Visiting professor in Biochemistry at the University of Piemonte Orientale (UPO), Novara, Italy 

  • 2013-2016 post-doctoral research scientist (Chargé de recherche), Unit of Pharmacology & Therapeutics, Research 

  • 2018-2014 Post doctoral fellow at the Dept. of Molecular Biotechnologies and Health Sciences and Molecular Imaging Center (www.cim.unito.it) of the University of Torino

EDUCATION AND TRAINING

  •  M.Sc. in Medical Biotechnologies, University of Turin, 2004, with a focus on Iron Metabolism.

  • Ph.D. in Molecular Medicine, University of Piemonte Orientale “A. Avogadro”, 2009, specializing in Muscle Mass Homeostasis.

  • Postdoctoral training in Cancer Metabolism and Angiogenesis, University of Louvain Medical School, 2010

HONORS

  • Eliezer Rachmilewitz Prize Recipient,at BioIron EMBL (2019) “Role of Iron metabolism in cancer cachexia”

  • Prix d’Alvarenga, de Piauhy (2015) “Role of mitochondrial superoxide targeting on tumor signaling and metastasis prevention”. Royal Belgian Academy of Medicine

  • Best scientific poster at the Biowin day 2012, Louvain LN, Belgium 28 Nov 2012.

  • Aegean Conference Trainee Award Tumor microenvironment and cellular stress conference, Chania Greece, 4-9 Oct, 2012

COMMISSIONS OF TRUST AND MEMBERSHIPS

  • Selected reviewer for PNAS, Oncogene, Science Signalling, Science Advances, Oncogenesis, Oncotarget, American Journal of Physiology, Trends in Cancer, Journal of Translational Medicine, Frontiers in Oncology, IJMS, Cancer Res

  • Grant Reviewer: Health Research Council (NZ) 2021, Swiss National Science Foundation-SNSF (CH)2020, 

  • MRC-University of Cambridge 2020,2019; National Fellowship Committee for Graduate Women in Science 2019; Research Foundation Flanders – FWO 2018, Luxembourg National Research Fund

Ultimo aggiornamento: